EnsiliTech key facts
as of Oct 2026- Developer of a healthcare technology platform designed to prevent vaccine spoilage and degradation during storage and transport.
- EnsiliTech is valued at approximately $4.0M as of Oct 2026 (last reported valuation).
- It has raised $7.5M.
- Notable investors include Innovate UK, Empirical Ventures, U.K. Department of Health & Social Care, Angel Investors Bristol, Calculus Capital — 21 tracked in total.
- Status: Privately Held (backing).
EnsiliTech's last reported valuation, Dec 2022. Nothing priced has surfaced since.
- ·The complete investor list: 21 names
- ·Watch EnsiliTech: the Monday email on marks, rounds and moves
EnsiliTech funding rounds
No funding rounds for EnsiliTech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs EnsiliTech
21+EnsiliTech valuation
EnsiliTech's last reported valuation was $4 million in Dec 2022. No priced round, secondary trade or fund mark has surfaced since.
EnsiliTech investors
21 investors are on record for EnsiliTech, including Innovate UK, Empirical Ventures, U.K. Department of Health & Social Care and Angel Investors Bristol.
About EnsiliTech
Developer of a healthcare technology platform designed to prevent vaccine spoilage and degradation during storage and transport. The company's platform offers silica-based encapsulation that forms protective nanoshells around biopharmaceutical components to reduce environmental damage and aggregation, enabling vaccine manufacturers and global health organizations to extend shelf stability, reduce wastage, and support broader access.
- Sector
- Healthcare
- HQ
- Bristol, United Kingdom
- Founded
- 2021
- Employees
- 14
- Website
- ensilitech.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.